Why package is important to medicine?

Although medical packaging looks inconspicuous, it cannot be belittled.

No matter of humidity, cleanness parameters or electronic supervision code challenges medical packaging production. As its direct downstream industry is drug, the quality regulation of medical packaging look vital.

It is the attraction of medical packaging that plays an important role in medical brand influence development, competition in drugs sales market and medical product quality guarantee.

As it is known, China regulates drugs production more strictly according to new GMP and unannounced inspection. Pharmaceutical enterprises replace manual packing with automatic cartoning machine to reduce drugs pollution and labor cost. In addition, people are aware of healthcare and their medical demand increases because of the aging. Therefore, sufferers gradually choose drugs by themselves. Since the nation implemented strategy of quantity purchase, pharmaceutical enterprises have increased their investment. All in all, drugs sales market is potential.

Data shows: drugs sales value of China in 2018 reached RMB 393.1 billion, in which terminal drugs sales takes up 22.9%. On this basis, some organizations estimated that the market value of outflow prescription after quantity purchase would reach about RMB 300 billion and make an increase for drugs sales market by 50%.

Some experts express that medical packaging industry, as an upstream industry in medical production chains, have had pretty high compound annual growth rate for the past five years. Asia-Pacific market, mainly driven by China, has caught up with and surpassed European market and approached North American market. However, behind high speed increase, China’s medical industry is large but not strong. It features low overall industrial additional value, small enterprise size, low technical level, single product structure, and great shortage in labor, equipment and management compared with mature market in Europe and North America.

Therefore, some experts point out that enhancing industry concentration can be a vital path for China’s medical packaging market development. Regulation ideas and procedure systems of medicines can guide the improvement of medical packaging industry standard and regulations. As now downstream pharmaceutical enterprises have higher requirements on safety and reliability of packing materials, enterprises whose technology and management are backward will be eliminated, integrated and disappeared. In this process, capital plays an irreplaceable role as the adhesion, catalyzer and fusion agent for integration and upgrading of China’s medical packing.

As it is understood, China supports and encourages medical packaging industry to stimulate industry development and technology progress of its medical packaging. In recent years, a number of medical packaging enterprises have risen and taken their road on improving quality and technology. A company among them expresses that it adheres to enterprise purpose “quality-based, technology-driven and talent-strengthened”. It aims to build an internationally advanced medical packing material developing and producing base, devotes itself to develop, localize and industrialize high-end new medical packing materials and form strategic product layout of packing material for infusion represented by non-PVC multilayer coextrusion composite film, material for injection represented by macromolecular pre-filling syringe, and material for oral liquid and drug substances, food packing, industrial packing and biodegradable materials. These measures strongly support product structure adjustment and optimization, industrial chain lengthening, transformation and development. They also contribute to the upgrading and development of products of China’s medical packing industry.